Hyperthermia Blog

What's New, What's News, What's Happening

English French German Hindi Japanese

west indiesPlease welcome our new distribution partner,  Clinitech Company Ltd,  bringing the hyperthermia technologies into Cuba, the West Indies, Panama and Venezuela.

Cancer deaths are high (138 per 100,000) in Cuba, according to World Life Expectancy.com, an organization that tracks death causality throughout the world.  Cuba cancer stats rank 31 in the world, slightly lower than the UK, and several points higher than the USA.   According to a study in 2001-2003 by the National Cancer Registry, Lung, Prostate, Throat and Colon had high incidence in men, while Breast, Cervix, Lung and Colon cancers were the most prevalent in women.

clinitech logo v2

Clinitech will be providing sales and service for the Pyrexar family of Superficial, Interstitial and Deep Regional Hyperthermia devices. Leading their team is Ross University School of Medicine, Oncology Professor, Dr. Kamal Malaker, who has successfully used Hyperthermia technology in the treatment of cancer. “We are excited to bring this relatively under-explored, under utilized, well proven, life-saving technology to the region.” says Wazir Mohammed, Clinitech’s President.

The distribution territory includes: Antigua, Aruba, Bahamas, Barbados, Belize, Bermuda, Bonaire, British Virgin Islands, Cayman Islands, Cuba, Curacao, Dominica, Dominican Republic, Grenada, Guyana, Haiti, Jamaica, Montserrat, Panama, Puerto Rico, Saba, St. Ecstasies. St Kitts & Nevis, St Lucia, St Maarten, St Vincent. Suriname, Trinidad and Tobago. Turks and Caicos. US Virgin Islands (St. Thomas, St. Croix, St John), Venezuela. Visit the "How to Buy" page for contact information.

"It is important that Pyrexar continues our expansion to insure our cancer fighting system is offered worldwide, to all cancer patients" - Mark Falkowski, CEO.